Empagliflozin Trims Liver Fat in Patients With T2D and NAFLD Empagliflozin Trims Liver Fat in Patients With T2D and NAFLD
Dr Kuchay discusses his findings from the E-LIFT study.Endocrine Society
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology Commentary Source Type: news
More News: Diabetes | Empagliflozin | Endocrinology | Health | Jardiance | Liver | Non-alcoholic Fatty Liver Diseases (NAFLD) | Study | Urology & Nephrology